| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d348100bd1effa1915263418113f5832 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 |
| filingDate |
2017-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_486a891c463f56afb1e34c2dbf13013f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a1997165a4dcc5d63a0206cd7735e4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8321736441500fa596360543316d3745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1fccf66fdd4e6dd5d7748a583166de5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6365f6e83cd3c31547e9edaa2c5a9562
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56dd40dfd4618d15df6e9fe8b821194a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c84709e2a3cf04e6adcdd77563cf669c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d034f2dcd7fbf7a14055576dd0e316 |
| publicationDate |
2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10654851-B2 |
| titleOfInvention |
Deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof |
| abstract |
A type of deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof. The derivatives are compounds of Formula (I) or pharmaceutically acceptable salts thereof. These compounds or salts thereof can be used for treatment or prevention of diseases or illnesses through certain mutant forms of epidermal growth factor receptors, inhibit the growth of various tumor cells effectively, and inhibit other proteases of EGFR and Her families, they can be used for preparing anti-tumor drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11629144-B2 |
| priorityDate |
2016-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |